Lithium carbonate revitalizes tumor-reactive CD8 + T cells by shunting lactic acid into mitochondria

Jingwei Ma,Liang Tang,Yaoyao Tan,Jingxuan Xiao,Keke Wei,Xin Zhang,Yuan Ma,Shuai Tong,Jie Chen,Nannan Zhou,Li Yang,Zhang Lei,Yonggang Li,Jiadi Lv,Junwei Liu,Huafeng Zhang,Ke Tang,Yi Zhang,Bo Huang
DOI: https://doi.org/10.1038/s41590-023-01738-0
IF: 30.5
2024-01-23
Nature Immunology
Abstract:The steady flow of lactic acid (LA) from tumor cells to the extracellular space via the monocarboxylate transporter symport system suppresses antitumor T cell immunity. However, LA is a natural energy metabolite that can be oxidized in the mitochondria and could potentially stimulate T cells. Here we show that the lactate-lowering mood stabilizer lithium carbonate (LC) can inhibit LA-mediated CD8 + T cell immunosuppression. Cytoplasmic LA increased the pumping of protons into lysosomes. LC interfered with vacuolar ATPase to block lysosomal acidification and rescue lysosomal diacylglycerol–PKCθ signaling to facilitate monocarboxylate transporter 1 localization to mitochondrial membranes, thus transporting LA into the mitochondria as an energy source for CD8 + T cells. These findings indicate that targeting LA metabolism using LC could support cancer immunotherapy.
immunology
What problem does this paper attempt to address?